Rosaria Greco Selected Research

Hydrolases

1/2021

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosaria Greco Research Topics

Disease

38	Migraine Disorders (Migraine) 02/2024 - 10/2005
29	Pain (Aches) 11/2023 - 01/2003
22	Hyperalgesia 11/2023 - 01/2003
8	Stroke (Strokes) 03/2023 - 10/2014
7	Brain Ischemia (Cerebral Ischemia) 03/2023 - 02/2011
6	Ischemic Stroke 03/2023 - 01/2007
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2023 - 07/2012
4	Headache (Headaches) 11/2017 - 07/2010
3	Neuralgia (Stump Neuralgia) 11/2023 - 09/2018
3	Neuroinflammatory Diseases 01/2018 - 07/2012
3	Ischemia 07/2012 - 01/2007
2	Necrosis 03/2023 - 01/2003
2	Reperfusion Injury 01/2018 - 07/2012
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 09/2015
2	Diabetic Foot 03/2016 - 10/2014
2	Hypertension (High Blood Pressure) 03/2016 - 10/2014
2	Chronic Limb-Threatening Ischemia 10/2014 - 02/2014
1	Mental Disorders (Mental Disorder) 02/2024
1	Trigeminal Neuralgia (Tic Douloureux) 11/2023
1	Inflammation (Inflammations) 07/2022
1	Prescription Drug Overuse 01/2021
1	Cluster Headache (Cluster Headaches) 01/2019
1	Brain Infarction 01/2019
1	Thrombosis (Thrombus) 01/2018

Drug/Important Bio-Agent (IBA)

28	Nitroglycerin (Dynamite)FDA LinkGeneric 06/2023 - 01/2003
17	EndocannabinoidsIBA 02/2024 - 07/2010
17	Formaldehyde (Formol)FDA Link 06/2023 - 01/2003
10	Calcitonin Gene-Related PeptideIBA 11/2023 - 09/2017
8	anandamide (arachidonylethanolamide)IBA 11/2023 - 04/2011
8	CytokinesIBA 11/2023 - 01/2003
7	LipidsIBA 02/2024 - 07/2010
7	Messenger RNA (mRNA)IBA 11/2023 - 01/2015
5	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 11/2023 - 01/2021
5	EnzymesIBA 11/2023 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 03/2023 - 07/2012
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2017 - 03/2006
4	CannabinoidsIBA 11/2023 - 07/2010
4	Analgesics (Analgesic Drugs)IBA 05/2023 - 01/2003
3	NeuropeptidesIBA 11/2023 - 07/2018
3	URB937IBA 11/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2011
3	AnkyrinsIBA 11/2022 - 09/2017
3	Monoclonal AntibodiesIBA 03/2022 - 12/2020
3	Glutamic Acid (Glutamate)FDA Link 07/2018 - 03/2006
3	Receptor for Advanced Glycation End ProductsIBA 04/2017 - 07/2012
3	Estrogens (Estrogen)FDA Link 01/2017 - 10/2012
3	ProstaglandinsIBA 01/2007 - 01/2003
2	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 07/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 06/2021
2	Substance PIBA 07/2022 - 09/2017
2	palmidrolIBA 03/2022 - 01/2021
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 01/2021
2	CB2 Cannabinoid ReceptorIBA 01/2021 - 03/2014
2	AntibodiesIBA 10/2020 - 12/2014
2	N(G)-iminoethylornithineIBA 01/2018 - 02/2011
2	Monoacylglycerol LipasesIBA 01/2018 - 12/2015
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2017 - 03/2006
2	Insulin (Novolin)FDA Link 03/2016 - 10/2014
2	Protein Isoforms (Isoforms)IBA 12/2014 - 07/2012
2	NF-kappa B (NF-kB)IBA 02/2011 - 10/2005
1	JZP327AIBA 06/2023
1	1,3,4-oxadiazol-2(3H)-oneIBA 06/2023
1	CannabidiolIBA 05/2023
1	Carrier Proteins (Binding Protein)IBA 03/2023
1	AmidesIBA 07/2022
1	Peptides (Polypeptides)IBA 07/2022
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 07/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2022
1	CarbamatesIBA 07/2022
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2022
1	olcegepantIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 06/2021
1	Interleukin-4 (Interleukin 4)IBA 06/2021
1	InterleukinsIBA 06/2021
1	HydrolasesIBA 01/2021
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	incobotulinumtoxinA FDA Link 01/2021
1	AM 251 (AM251)IBA 01/2021
1	iodopravadoline (AM 630)IBA 01/2021
1	Glycerol (Glycerine)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 10/2020
1	erenumabIBA 10/2020
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 01/2020
1	NitratesIBA 01/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Volatile Oils (Essential Oils)IBA 09/2018
1	gamma-Aminobutyric Acid (GABA)IBA 07/2018
1	Topiramate (Topamax)FDA LinkGeneric 07/2018
1	URB602IBA 01/2018
1	Immunomodulating AgentsIBA 01/2018
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018
1	Kynurenic Acid (Kynurenate)IBA 11/2017

Therapy/Procedure

8	Therapeutics 03/2023 - 10/2005
2	Surgical Amputation (Amputations) 03/2016 - 10/2014
1	Injections 01/2021
1	Aromatherapy 09/2018
1	Mechanical Thrombolysis 01/2018